期刊文献+

不同去势方式治疗晚期前列腺癌的现状及进展 被引量:3

Current status and progress of different methods of castration for treatment of advanced prostate cancer
原文传递
导出
摘要 前列腺癌是老年男性常见的疾病之一,发现时多为晚期。对于晚期前列腺癌而言,其首选的治疗手段为内分泌治疗,其中以最大雄激素阻断疗法即去势+抗雄激素治疗最为常用,有关去势方式又可分为手术去势和药物去势。目前临床上对于手术或药物去势的选择虽有大量文献进行比较分析,但尚无统一的选择标准。本文就晚期前列腺癌内分泌治疗中不同去势方式的选择做一综述。 Prostate cancer is one of the common diseases in the elderly.It is found mostly late.Endocrine therapy is the first choice for the treatment of advanced prostate cancer,and maximum androgen blockade therapy,namely as castration plus anti-androgen treatment is most commonly used at present.The ways of castration can be classified as surgical castration and medical castration.There is still no uniform standard,though a large amount of literature has analyzed and compared between these two methods.In this paper,the selection of different methods of castration for the treatment of advanced prostate cancer will be reviewed.
出处 《临床泌尿外科杂志》 2016年第10期950-953,共4页 Journal of Clinical Urology
关键词 晚期前列腺癌 手术去势 药物去势 advanced prostate cancer surgical castration medical castration
  • 相关文献

参考文献27

  • 1Heidenreich A,Bellmunt J,Bolla M,et al.EAUguidelines on prostate cancer.Part 1:screening,diagnosis,and treatment of clinically localised disease[J].Eur Urol,2011,59(1):61-71.
  • 2Kunath F,Grobe H R,Rucker G,et al.Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer:a Cochrane systematic review[J].BJU Int,2015,116(1):30-36.
  • 3Ayyathurai R,Santos R L,Manoharan M.Role of maximum androgen blockade in advanced prostate cancer[J].Indian J Urol,2009,25(1):47-51.
  • 4Labrie F.GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer[J].Endocr Relat Cancer,2014,21(4):R301-R317.
  • 5彦群,叶章群,孙颖浩,等主编.2014版中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2014:72.
  • 6Zhang X Z,Donovan M P,Williams B T,et al.Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer[J].Urology,1996,47(3):402-404.
  • 7蒋玉清,吴国柱,王伟,贾晓鹏,王秀丽,郭跃先.手术去势和药物去势治疗前列腺癌疗效的回顾性研究[J].河北医药,2015,37(21):3234-3236. 被引量:8
  • 8孙颖浩,高旭.前列腺癌内分泌治疗的合理选择[J].现代泌尿外科杂志,2007,12(1):1-3. 被引量:7
  • 9Armstrong A J,Garrett-Mayer E,de Wit R,et al.Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer[J].Clin Cancer Res,2010,16(1):203-211.
  • 10Weckermann D,Harzmann R.Hormone therapy in prostate cancer:LHRH antagonists versus LHRH analogues[J].Eur Urol,2004,46(3):279-283,283-284.

二级参考文献50

  • 1Huggins SC, Hodges W. The effects of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res,1941,1:292-297.
  • 2Marc BG. Hormonal therapy in the management of prostate cancer:from Huggins to the present. Urology, 1997,49( suppl 3A) :5-15.
  • 3Dirnhofer S, Berger C, Hermann M,et al. Coexpression of gonadotrophic hormones and their corresponding FSH and LH/CG receptors in the human prostate. Prostate, 1998,35:212-217.
  • 4Halos G, Schally AV, Botwick DG,et al. High incidence of receptors for LHRH and LHRH receptor gene expression in prostate cancer. JUrol,2000,163:623-629.
  • 5Miyamoto H,Messing EM,Chang C.Androgen deprivation therapy for prostate cancer:current status and future prospects.Prostate,2004,61:332-353.
  • 6Grossfeld GD,Chaudhary UB,Reese DM,et al.Intermittent androgen deprivation:update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.Urology,2001,58:240-245.
  • 7Cooperberg MR,Broering JM,Litwin MS,et al.The contemporary management of prostate cancer in the United States:lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE),a national disease registry.J Urol,2004,171:1393-1401.
  • 8Vogelzang NJ,Chodak GW,Soloway MS,et al.Goserelin versus orchiectomy in the treatment of advanced prostate cancer:final results of a randomized trial.Zoladex Prostate Study Group.Urology,1995,46:220-226.
  • 9Sato N,Gleave ME,Bruchovsky N,et al.Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.J Steroid Biochem Mol Bio1,1996,58:139-146.
  • 10de Leval J,Boca P,Yousef E,et al.Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer:results of a prospective randomized multicenter trial.Clin Prostate Cancer,2002,1:163-171.

共引文献60

同被引文献31

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部